Methenamine Hippurate (Winthrop U.S.)


Welcome to the PulseAid listing for the Methenamine Hippurate drug offered from Winthrop U.S.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Winthrop U.S.
NON-PROPRIETARY NAME: Methenamine Hippurate
SUBSTANCE NAME: METHENAMINE HIPPURATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-01-23
END MARKETING DATE: 0000-00-00


Methenamine Hippurate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethenamine Hippurate from Winthrop U.S.
LABELER NAME: Winthrop U.S.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2012-01-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0955-1037_9188940f-72bf-428e-8c6a-789e0fe24a78
PRODUCT NDC: 0955-1037
APPLICATION NUMBER: NDA017681

Other METHENAMINE HIPPURATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Methenamine Hippurate
Aurobindo Pharma LimitedMethenamine Hippurate
Carilion Materials ManagementMethenamine Hippurate
CorePharma, LLCMethenamine Hippurate
County Line Pharmaceuticals, LLCMethenamine Hippurate
Leading Pharma, LLCMethenamine Hippurate
Sanofi-Aventis U.S. LLCHiprex
Validus Pharmaceuticals LLCHIPREX
Winthrop U.S.Methenamine Hippurate